cycloserine has been researched along with terizidone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Kirtaeva, OV; Lazareva, IaR; Romanova, EV; Sokolova, GB; Tsybane, AA | 1 |
| Andries, K; Bantubani, N; De Marez, T; Diacon, AH; Donald, PR; Grobusch, M; Lounis, N; Mahanyele, R; McNeeley, DF; Meyvisch, P; Narasimooloo, R; Patientia, RF; Pym, A; van Heeswijk, R | 1 |
| Davis, JG; Farley, J; Lancaster, J; Odendaal, R; Shean, K; Van der Walt, M | 1 |
| Hwang, TJ; Jafarov, A; Jakubowiak, W; Keshavjee, S; Nunn, P; Wares, DF | 1 |
| Alffenaar, JWC; Migliori, GB; Peloquin, CA | 1 |
| Court, R; de Vries, N; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Stewart, A; Wiesner, L | 1 |
| Martins Dos Santos, VAP; Rienksma, RA; Schaap, PJ; Suarez-Diez, M | 1 |
| Becker, P; Keddy, KH; Lancaster, J; Shean, K; van der Walt, ML | 1 |
| Centner, CM; Chirehwa, M; Court, R; de Vries, N; Denti, P; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Wiesner, L | 1 |
1 review(s) available for cycloserine and terizidone
| Article | Year |
|---|---|
Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis.
Topics: Antibiotics, Antitubercular; Central Nervous System Diseases; Cycloserine; Humans; Isoxazoles; Mental Disorders; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2013 |
2 trial(s) available for cycloserine and terizidone
| Article | Year |
|---|---|
[Rezonizat and cycloserine in complex therapy of drug resistant tuberculosis (comparative studies)].
Topics: Adult; Antibiotics, Antitubercular; Cycloserine; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Oxazolidinones; Tuberculosis, Multidrug-Resistant; Young Adult | 2008 |
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.
Topics: Antitubercular Agents; Clarithromycin; Cycloserine; Dapsone; Diarylquinolines; Erythromycin; Female; Humans; Isoxazoles; Male; Ofloxacin; Oxazolidinones; Quinolines; Tuberculosis, Multidrug-Resistant | 2012 |
6 other study(ies) available for cycloserine and terizidone
| Article | Year |
|---|---|
Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients.
Topics: Adult; Antitubercular Agents; Coinfection; Cycloserine; Drug Resistance, Multiple, Bacterial; Female; Hearing Loss; HIV Infections; Humans; Isoxazoles; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Prospective Studies; Psychoses, Substance-Induced; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone.
Topics: Antitubercular Agents; Cycloserine; Humans; Isoxazoles; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Area Under Curve; Chromatography, Liquid; Cycloserine; Female; HIV Infections; Humans; Isoxazoles; Male; Middle Aged; Oxazolidinones; Prospective Studies; Regression Analysis; South Africa; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Modeling Host-Pathogen Interaction to Elucidate the Metabolic Drug Response of Intracellular
Topics: Adenosine Triphosphatases; Amides; Amino Acids; Antitubercular Agents; Cycloserine; Diarylquinolines; Drug Tolerance; Ethambutol; Ethionamide; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Host-Pathogen Interactions; Humans; Isoniazid; Isoxazoles; Metabolic Networks and Pathways; Models, Biological; Mycobacterium bovis; Mycobacterium tuberculosis; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis | 2019 |
Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa.
Topics: Adult; Antitubercular Agents; Cycloserine; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoxazoles; Oxazolidinones; Pharmaceutical Preparations; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2020 |
Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Cycloserine; Depression; Female; HIV Infections; Humans; Incidence; Isoxazoles; Male; Middle Aged; Oxazolidinones; Peripheral Nervous System Diseases; Prospective Studies; Psychoses, Substance-Induced; Risk Factors; Tuberculosis, Multidrug-Resistant | 2021 |